Click image to zoom
Sanofi 15 Billion Sale Of Opella And Doliprane To CDR
BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
Photo Details
| Photo ID | #11661393 |
|---|---|
| Date Taken | |
| Location | N/A |
| Photographer | Artur Widak/NurPhoto |
| Category | Economy, Business and Finance |
| Copyright | © 2026 NurPhoto - Artur Widak/NurPhoto |
Related Keywords
Acquisition
Agreement
Assets
Billion
Brand
Business
Buyout
CD&R
Capital
Clayton
Clayton Dubilier & Rice
Commercial
Company
Competition
Consumer-products
Corporate
Deal
Deal-structure
Divestment
Doliprane
Dubilier
Equity
Europe
Euros
Exit
Expansion
Financial
France
Fund
Global
Growth
Health
Healthcare
Industry
Innovation
Integration
Investment-fund
Market
Medicine
Merger
Opella
Over-the-counter
Ownership
Painkillers
Portfolio
Pricing
Restructure
Rice
Sale
Sanofi
Strategy
Synergy
Transaction
Transfer
USA
Valuation
consumer
investment
move
pharmaceutical
products
profit
revenue
strategic
Bayeux
France
Doliprane
Sanofi
pharmaceutical
consumer healthcare
Opella
Clayton Dubilier and Rice
CDandR
investment fund
divestment
business sale
consumer health products
euros
Calvados
France
October 2024
Artur Widak
NurPhoto
American investment
healthcare division
Sanofi logo
boxes
computer screen
world's fifth-largest
pharmaceutical company
sale transaction
1000g
divesting
portion of business
healthcare
investment
photo.
2026 NurPhoto. All rights reserved.
This image is the property of NurPhoto and is protected under international copyright laws.
Similar Photos
View All
